Acuta Capital Partners’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-125,000
| Closed | -$1.6M | – | 36 |
|
|
2022
Q3 | $1.6M | Buy |
+125,000
| New | +$1.6M | 0.69% | 29 |
|
|
2021
Q4 | – | Sell |
-150,000
| Closed | -$1.7M | – | 38 |
|
|
2021
Q3 | $1.7M | Buy |
+150,000
| New | +$1.7M | 0.6% | 35 |
|
|
2021
Q2 | – | Sell |
-407,055
| Closed | -$5.75M | – | 38 |
|
|
2021
Q1 | $5.75M | Sell |
407,055
-171,445
| -30% | -$2.42M | 2.07% | 21 |
|
|
2020
Q4 | $6.53M | Sell |
578,500
-109,500
| -16% | -$1.24M | 1.78% | 23 |
|
|
2020
Q3 | $9.08M | Buy |
688,000
+150,500
| +28% | +$1.99M | 2.47% | 13 |
|
|
2020
Q2 | $5.76M | Buy |
+537,500
| New | +$5.76M | 1.66% | 26 |
|